Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Angiodynamics, Inc. (ANGO)
:ANGO
ANGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.26 - $13.50
Previous CloseN/A
Volume2.49M
Average Volume (3M)856.61K
Market Cap
$428.53M
Enterprise Value$234.41M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Apr 03, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.58
Shares Outstanding40,465,710
10 Day Avg. Volume365,707
30 Day Avg. Volume856,611
Standard Deviation0.15
R-Squared0.05
Alpha-0.00002
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.54
Price to Cash Flow (P/CF)44.50
P/FCF Ratio44.50
Enterprise Value/Market Cap0.55
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.52
Enterprise Value/Ebitda-16.24
Forecast
1Y Price Target
$15.33Price Target Upside44.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
AngioDynamics News
PremiumCompany Announcements
AngioDynamics Earnings Call Highlights Med Tech Growth
PremiumCompany Announcements
AngioDynamics Highlights Strategic Growth at Healthcare Conference
PremiumCompany Announcements
AngioDynamics, Inc. Reports Growth in Med Tech Segment---
Bulls Say, Bears Say
Bulls Say
FDA ApprovalFDA approves NanoKnife System for prostate tissue ablation.
Sales GrowthThe FDA clearance should enable the company to expand the commercial footprint of NanoKnife, which could help drive the company’s Med Tech sales growth.
Bears Say
Market CompetitionThe prostate market is a $700M opportunity in the US and $2B globally, indicating significant competition and challenges in capturing market share.
---
Ownership Overview
4.16% Insiders
17.64% Mutual Funds
25.76% Other Institutional Investors
39.73% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ANGO FAQ
What was Angiodynamics, Inc.’s price range in the past 12 months?
Angiodynamics, Inc. lowest stock price was $5.26 and its highest was $13.50 in the past 12 months.
What is Angiodynamics, Inc.’s market cap?
Angiodynamics, Inc.’s market cap is $428.53M.
When is Angiodynamics, Inc.’s upcoming earnings report date?
Angiodynamics, Inc.’s upcoming earnings report date is Apr 03, 2025 which is in 40 days.
How were Angiodynamics, Inc.’s earnings last quarter?
Angiodynamics, Inc. released its earnings results on Jan 08, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.11 by $0.07.
Is Angiodynamics, Inc. overvalued?
According to Wall Street analysts Angiodynamics, Inc.’s price is currently Undervalued.
Does Angiodynamics, Inc. pay dividends?
Angiodynamics, Inc. does not currently pay dividends.
What is Angiodynamics, Inc.’s EPS estimate?
Angiodynamics, Inc.’s EPS estimate is -0.13.
How many shares outstanding does Angiodynamics, Inc. have?
Angiodynamics, Inc. has 40,465,710 shares outstanding.
What happened to Angiodynamics, Inc.’s price movement after its last earnings report?
Angiodynamics, Inc. reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.11. Following the earnings report the stock price went up 37.66%.
Which hedge fund is a major shareholder of Angiodynamics, Inc.?
Currently, no hedge funds are holding shares in ANGO
---
AngioDynamics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.33 (44.76% Upside)
$15.33 (44.76% Upside)
Blogger Sentiment
Bullish
ANGO Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $50.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.5%
Last 30 Days ▼ 9.6%
Last 30 Days ▼ 9.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
74.46%
12-Months-Change
Fundamentals
Return on Equity
-76.44%
Trailing 12-Months
Asset Growth
-41.65%
Trailing 12-Months
Company Description
Angiodynamics, Inc.
AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.
---
ANGO Company Deck
---
ANGO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in revenue growth and profitability, especially within the Med Tech segment, driven by innovations like AlphaVac and NanoKnife. However, challenges persist in Med Device revenue stagnation and manufacturing transition costs, tempering overall financial improvements.Read More>---
ANGO Stock 12 Month Forecast
Average Price Target
$15.33
▲(44.76% Upside)
Technical Analysis
Best Analysts Covering ANGO
1 Year
1 Year Success Rate
10/12 ratings generated profit
1 Year Average Return
+40.77%
reiterated a buy rating last month
Copying Yi Chen's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +40.77% per trade.
---